LSBio
IHC-plus™ HNRPM / HNRNPM Antibody (clone 3F7)

Anti-HNRNPM / HNRPM antibody IHC of human placenta. Immunohistochemistry of formalin-fixed, paraffin-embedded tissue after heat-induced antigen retrieval. Antibody concentration 5 ug/ml.

IHC-plus™ HNRPM / HNRNPM Antibody (clone 3F7)

Primary AntibodyLSBio Guarantee
Antibody:Mouse Monoclonal
Applications:Enzyme-Linked Immunosorbent Assay, Immunofluorescence, Immunohistochemistry (general), Immunohistochemistry, Paraffin, Western Blot
Reactivity:Human, Mouse, Rat
Format:Liquid
See all HNRPM / HNRNPM antibodies →
$383.00each
Catalog Number: LS-B4384-50

For bulk orders or custom formulations:

Request a Quote

Overview

Description
HNRNPM antibody LS-B4384 is an unconjugated mouse monoclonal antibody to HNRNPM (HNRPM) from human. It is reactive with human, mouse and rat. Validated for ELISA, IF, IHC and WB. Tested on 20 paraffin-embedded human tissues. Cited in 1 publication.
Application
ELISA, IF, IHC, IHC-P, WB
Reactivity
Hu, Ms, Rt
Intended Use
Research Use Only
Guarantees
This product carries the LSBio 100% Guarantee.
Category
Antibodies > Primary Antibodies > Monoclonal Antibodies
Alternative Names
CEA receptor | CEAR | HnRNA-binding protein M4 | HNRNPM | HNRNPM4 | HNRPM4 | N-acetylglucosamine receptor 1 | NAGR1 | HnRNP M | HNRPM | HTGR1
Recommended Dilution: IF/ICC
10 µg/ml
Recommended Dilution: IHC-P
5 µg/ml
UniProt Number
P52272
SwissProt
P52272

Target

Target
HNRPM / HNRNPM
Antigen Species
Human
Gene Name
HNRNPM

Antibody

Host Species
Mouse
Clonality
Monoclonal
Clone
3F7
Light Chain
Kappa Light Chain
Origin Species
Human

Immunogen

Immunogen
HNRPM (NP_005959, 17 aa ~ 113 aa) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa.

Format

Conjugate/Label
Unconjugated
Format
Liquid
Formulation
PBS, pH 7.4
Animal Free
No
Carrier-Free
Yes
Purification Method
Protein A Affinity

Storage & Handling

Storage Conditions
Store at -20°C. Aliquot to avoid freeze/thaw cycles.
Recommended Storage Buffer
PBS
The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer. Bjersand K, Seidal T, Sundström-Poromaa I, Åkerud H, Skirnisdottir I. PloS one. 2017 June;12:e0179363. PubMed: 28609484 PMC: PMC5469483

Request SDS/MSDS

To request an SDS/MSDS form for this product, please contact our Technical Support department at: technical@vectorlabs.com.